5th Applied Biocatalysis and Enzyme Engineering Summit

Memo

As new tools and techniques emerge rapidly in the wake of the AI boom, the challenge remains in applying these innovations to industrial uses of biocatalysis to enable faster, more scalable workflows and drive true innovation in enzyme engineering. Uniting biopharma, commodity chemicals, fine chemicals, academia, and solution providers, the 5th Applied Biocatalysis and Enzyme Engineering Summit returns with a renewed focus on practical implementation of new tools and cross-sector collaboration. No matter your specific department or the maturity of your group, this is your one-stop shop to join 80+ experts in discussing the most pressing challenges in biocatalysis. With case studies and practical insights from Amgen, Takeda, Eli Lilly, Pfizer, Merck, and Vertex Pharmaceuticals, and more, this is your opportunity to explore proven strategies to integrate AI-driven methodologies, accelerate engineering timelines, and scale with confidence. URLs:Tickets: https://go.evvnt.com/3229904-2?pid=5569 Brochure: https://go.evvnt.com/3229904-3?pid=5569  Date and Time: Wed, 12 Nov 2025 08:00 - Thu, 13 Nov 2025 17:00 Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States Prices:Conference Pass - Drug Developers, Commodity Chemicals, Fine Chemicals, and Academics: USD 0.50,Conference Pass - Solution Providers: USD 3699.00 Speakers: Adrian Ortiz, Executive Director, Process Research and Development, Eli Lilly and Co., Amarjit Singh, Associate Scientific Fellow, Takeda Pharmaceutical, Amelia Gilio, Postdoctoral Research Fellow in Biocatalysis, Pfizer, Davide Panigada, Head of Enzyme Biology, Sanofi, Deeptak Verma, Director of Computational Chemistry (Modeling and Informatics), Merck and Co, Douglas Millar, Senior Scientist, Process Development, Amgen Inc., Erin Obrien, Head of Process Chemistry, Synthetic Molecule Process Development, Takeda Pharmaceutical, Hans Renata, Professor, Rice University, Hardwin O’Dowd, Research Fellow, Vertex Pharmaceuticals, Harrison Snodgrass, Senior Scientist, Merck and Co, Jason Donald, Senior Director, Protein Engineering, Stylus Medicine, Jason Tedrow, Global Head of Process Chemistry, Sanofi, Jeffrey Kohrt, Senior Principal Scientist, Pfizer, Kaitlin Chambers, Principal Scientist, Alnylam Pharmaceuticals, Leila Mashouf, Co-Founder and Chief Technology Officer, Rubi Laboratories, Michael Delaney, Senior Principal Scientist, Novo Nordisk, Michael Miller, Principal Scientist, International Flavors and Fragrances, Sam Mallinson, Researcher III, National Renewable Energy Laboratory (NREL), Tyler Fulton, Senior Scientist, Abbvie, Zhaohui Sunny Zhou, Professor and Faculty Fellow, Northeastern University